The National COVID-19 Clinical Evidence Taskforce was formed just four weeks ago to sift through that evidence and provide “living” guidelines for clinicians, which are being updated weekly – how on earth do they keep on top of it all?
COVID-19 research is being produced at a rate of 500 papers a day, and speeding up.
The National COVID-19 Clinical Evidence Taskforce was formed just four weeks ago to sift through that evidence and provide “living” guidelines for clinicians, which are being updated weekly – how on earth do they keep on top of it all?
What do they do in the absence of large, rigorous studies?
And when science is flying out of the labs and wards, is quality compromised?
TMR’s Penny Durham spoke to the taskforce’s chairman, Associate Professor Julian Elliott.
If you have clinical COVID questions you’d like the taskforce to address, go to covid19evidence.net.au – they want to hear from you.
